cas 1431728-34-5|| where to buy 4-(4,5-Dihydrooxazol-2-yl)-1,2,5-oxadiazol-3-amine

Nom du produit:4-(4,5-Dihydrooxazol-2-yl)-1,2,5-oxadiazol-3-amine

IUPAC Name:4-(4,5-dihydro-1,3-oxazol-2-yl)-1,2,5-oxadiazol-3-amine

Unité d'emballage	Stock disponible	Prix($)	Quantité
CM504319-1g	in stock	ňŭň

Pour une utilisation en R&D uniquement..

Formulaire de demande

Nom chimique

Numéro CAS

Quantité*

Spécifications requises*
(% d'analyse, qualité du matériau, etc.)

Nom du contact*

Email du contact*

Meanwhile I'd like to create a registered account on CHEMENU.COM with the above email.

I'd like to receive emails related to products with similar structures to 1431728-34-5 regularly via the above email.

Notes supplémentaires

Verification code*

refresh

: N° CAS:1431728-34-5; Formule moléculaire:C5H6N4O2; Point de fusion:-; Code SMILES:NC1=NON=C1C2=NCCO2; Densité:

: Numéro de catalogue:CM504319; Poids moléculaire:154.13; Point d'ébullition:; N° Mdl:; Stockage:

: Oxazolines; Oxazolines are five-membered heterocyclic compounds with one double bond. The double bond may be in one of three positions, so there may be three different oxazoline rings. The 2-oxazoline structure is the most common, and 3-oxazoline and 4-oxazoline exist mainly as laboratory research compounds. Oxazolines exist between oxazole and oxazolidine in terms of saturation.

: Furazans; Incorporation of heterocycles into drug molecules can enhance physical properties and biological activity. Oxadiazoles are a class of five-membered heterocycles containing one oxygen and two nitrogen atoms with special biological activity and thermodynamic properties. 1,2,4- and 1,3,4-oxadiazoles are widely used in the development of bioactive molecules, but 1,2,5-oxadiazoles (furazans) are used relatively sparingly. Compared with 1,2,4- and 1,3,4-isomers, 1,2,5-oxadiazole has unique physicochemical properties and electronic effects. The furazan ring has a strong inductive effect, comparable to that of trifluoromethyl or tetrazolyl. The unique properties of furoxan can confer specific pharmacological activities to drug-like molecules.